adrenaline (epinephrine) acid tartrate - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
ADRENALINE-LINK 1:10,000 1mg/10mL adrenaline (epinephrine) acid tartrate injection BP pre filled syringe
AUST R: 210672
Active ingredients:
adrenaline (epinephrine) acid tartrate

Dosage form:
Injection, solution

Sponsor:
Link Medical Products Pty Ltd T/A Link Pharmaceuticals

Phone:
1800 181 060

From
23 Feb 2026
to
27 Mar 2026

Shortage status:
Current

Availability:
Limited Availability

Reason:
Transport / Logistic issues / Storage capacity issues

Management action:
The sponsor is working to expedite the next shipment. An alternative brand is available.
BUPIVADREN Bupivacaine 0.25% w/v with Adrenaline (epinephrine) 1:400,000 injection solution vial
AUST R: 292526
Active ingredients:
adrenaline (epinephrine) acid tartrate
bupivacaine hydrochloride monohydrate

Dosage form:
Injection, solution

Sponsor:
Pfizer Australia Pty Ltd

Phone:
1800-675-229

Deletion from market:
01 Sep 2025

Shortage status:
Discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
Alternative generic product is available.
BUPIVADREN Bupivacaine 0.5% w/v with Adrenaline (epinephrine) 1:200,000 injection solution vial
AUST R: 292528
Active ingredients:
adrenaline (epinephrine) acid tartrate
bupivacaine hydrochloride monohydrate

Dosage form:
Injection, solution

Sponsor:
Pfizer Australia Pty Ltd

Phone:
1800-675-229

Deletion from market:
01 Sep 2025

Shortage status:
Discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
Alternative generic products are available.